Athira Pharma, Inc. (ATHA) Tops Q2 EPS by 4c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• Sk Hynix To Pay 60% Of Employee Bonuses In Company Stock, Says Source - Reuters